1-(Bis(4-chlorophenyl)methyl)piperazine

Catalog No. :
ACSZWN698
CAS No. :
27469-61-0
Molecular Formula :
C17H18Cl2N2
Molecular Weight :
321.25

IUPAC Name:1-(bis(4-chlorophenyl)methyl)piperazine

1-(Bis(4-chlorophenyl)methyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$111.00Login to see priceIn stockIn stock
25g98%$538.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Bis(4-chlorophenyl)methyl)piperazine
IUPAC Name1-(bis(4-chlorophenyl)methyl)piperazine
MDL No.MFCD00191212
Molecular FormulaC17H18Cl2N2
Molecular Weight321.25
SMILESClC1=CC=C(C=C1)C(N2CCNCC2)C3=CC=C(Cl)C=C3
InChI KeyPTLFMGDNZYQISN-UHFFFAOYSA-N
Synonym1,3,5[10]-ESTRATRIENE-3,16ALPHA,17BETA-TRIOL3-CARBOXYMETHYLETHER | NSC142496 | NSC-142496 | MFCD00191212 | SCHEMBL1137956 | 1-(4,4'-Dichlorobenzhydryl)piperazine | FT-0600963 | PS-7041 | 1-[Bis-(4-chloro-phenyl)-methyl]-piperazine | 1-[bis(4-chlorophenyl)
CAS No.27469-61-0
PubChem CID285510

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H314-H332
Precautionary Statement(s)
P260-P261-P264-P270-P271-P280-P301+P312-P301+P330+P331-P302+P352-P303+P361+P353-P304+P340-P305+P351+P338-P310-P312-P321-P330-P363-P405-P501

Synthetic Route by SureRoute

1. ACSZWN698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACDQRM160 route compound structure diagram
    ACDQRM160782-08-1 In Stock
  4. Then
  5. ACSZWN698 route product structure diagram
    ACSZWN69827469-61-0 In Stock
Inquiry

2. ACSZWN698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSZWN698 route product structure diagram
    ACSZWN69827469-61-0 In Stock
Inquiry

Comments (0)